NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,960 | -1.9% | 2,837 | -2.8% | 0.09% | -1.1% |
| Q2 2023 | $294,541 | -2.2% | 2,919 | -10.8% | 0.09% | -8.1% |
| Q1 2023 | $301,068 | +2.0% | 3,272 | +2.1% | 0.10% | -2.0% |
| Q4 2022 | $295,176 | -10.2% | 3,206 | -17.6% | 0.10% | -19.2% |
| Q2 2022 | $328,729 | -3.5% | 3,889 | +0.2% | 0.12% | -3.1% |
| Q1 2022 | $340,689 | -4.1% | 3,882 | -6.6% | 0.13% | -35.2% |
| Q1 2021 | $355,223 | – | 4,156 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |